Evidence map›Paper›PMID 40091119›Full record

ArticleJournal of cannabis research2025

Utilization of medicinal hemp: a qualitative analysis of clinicians' perspectives in Ghana.

Radolf Ansbert Nortey, Anoa Aidoo, Seth Kwabena Amponsah

Abstract read
In one paragraph

Article in Journal of cannabis research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Radolf Ansbert NorteyDepartment of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), PMB, Kumasi, Ghana. ansbertn@gmail.com.ORCID http://orcid.org/0000-0001-9443-5010
Anoa AidooDepartment of Pharmacy Practice and Clinical Pharmacy, University of Ghana School of Pharmacy, Accra, P.O. Box LG 43 Legon, Ghana.
Seth Kwabena AmponsahDepartment of Pharmacology, University of Ghana Medical School, Accra, P.O. Box LG 43, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have explored the perspectives of health care professionals on the use of medicinal hemp, but they were mostly situated in high income countries. This study sets out to investigate the knowledge, attitudes, and beliefs of health care professionals regarding the use of hemp in clinical therapy vis-à-vis the legislative framework in Ghana.

objectiveTo explore the perspectives of physicians on the use of medicinal hemp and its legalization in Ghana.

methodA qualitative study employing purposive sampling and face-to-face in-depth interviews was conducted among twenty (20) physicians practicing in Ghana. The interviewees were selected based on specialty and scope of practice. The in-depth interviews were audio recorded, transcribed, and thematically analyzed using the Theory of Planned Behavior.

resultsTwenty (20) clinicians participated in the study. Fourteen (14) respondents were male and six (6) were female. The medical specialties of the interviewees were anaesthesiology, oncology, neurology, and orthopaedics. The identified themes include clinical use, stigma (sociocultural classification of cannabis), clinical non-prescription, policy landscape and regulatory control.

conclusionPrescribers' intention to recommend medicinal hemp is influenced by a complex interplay of various socio-political factors such as knowledge, policy, cultural environment, and stigma.

Indexed as

AfricaCannabinoidsDoctorsGhanaLegislationMedicinal hempTherapeutic

Identifiers

PMID40091119
PMCPMC11912765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.